DNUT · Krispy Kreme, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on DNUT. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About DNUT · Krispy Kreme, Inc.
Krispy Kreme, Inc., together with its subsidiaries, produces doughnuts in the United States, the United Kingdom, Ireland, Australia, New Zealand, Mexico, Canada, Japan, and internationally. It operates in three segments: U.S., International, and Market Development. The company offers doughnut experiences through hot light theater and fresh shops, delivers fresh daily branded cabinets and merchandising units within grocery and convenience stores, quick service restaurants, club memberships, drug stores, and digital channels, including delivery apps. It also operates Krispy Kreme company-owned shops and franchise shops. The company was formerly known as Krispy Kreme Doughnuts, Inc. and changed its name to Krispy Kreme, Inc. in May 2021. Krispy Kreme, Inc. was founded in 1937 and is based in Charlotte, North Carolina.
Live Quote
SELL (score -4) · 12-1 mom 28.1% · RSI 44.2 · below_both · -26.6% from high
Targets blend Wall Street consensus (6 analysts: low $3.00 / mean $4.35 / high $6.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Krispy Kreme shows a genuine insider cluster — director Bernardo Hees made a confirmed open-market purchase ($87K at $3.49 on June 5) while four C-suite executives received RSU vestings tied to April 2029 cliff schedules. The company is mid-turnaround: it completed two refranchising transactions in Q1 (Japan and W.K.S. Krispy Kreme), generated ~$111M in proceeds, narrowed operating losses substantially year-over-year, and has guided toward profitability. However, the stock trades at an extreme forward P/E of 80x with negative net margin (-33%), a dangerously levered balance sheet (D/E: 201%, net debt/EBITDA elevated), declining revenues, and just completed a large secondary offering dilution event that was flagged in Q1 filings. The June 10 annual meeting passed all proposals including an amended Omnibus Incentive Plan — routine. No named catalyst beyond the August 6 earnings date exists within the window.